Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Selby

Showing results (71-80 of 108) with videos related to

Pageof 11
Sort By:
Electrophoresis|May 27, 1999
The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis--preliminary findingsR E Banks, M J Dunn, M A Forbes, et al.
British Journal of Cancer|March 1, 1989
The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantationP J Selby, R L Powles, D Easton, et al.
Cancer Gene Therapy|August 13, 2011
Adenovirus-mediated hypoxia-targeted gene therapy using HSV thymidine kinase and bacterial nitroreductase prodrug-activating genes in vitro and in vivoT J Harvey, I M Hennig, S D Shnyder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
High-dose melphalan for multiple myeloma: long-term follow-up dataD Cunningham, L Paz-Ares, M E Gore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Automated collection of quality-of-life data: a comparison of paper and computer touch-screen questionnairesG Velikova, E P Wright, A B Smith, et al.
British Journal of Cancer|November 11, 2010
Improving the accuracy of pre-operative survival prediction in renal cell carcinoma with C-reactive proteinS P K Jagdev, W Gregory, N S Vasudev, et al.
Hybridoma|August 1, 1997
Production and characterization of monoclonal antibodies to human interleukin-12R W Carter, P M Patel, A J Stanley, et al.
British Journal of Cancer|March 2, 2013
miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosisR I McCormick, C Blick, J Ragoussis, et al.
British Journal of Cancer|December 1, 1988
High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytomaE K Mbidde, P J Selby, T J Perren, et al.
British Journal of Haematology|December 21, 2000
Persistence of clonal T-cell expansions following high-dose chemotherapy and autologous peripheral blood progenitor cell rescueA S Protheroe, C Pickard, P W Johnson, et al.
Pageof 11

Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
Electrophoresis|May 27, 1999
The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis--preliminary findingsR E Banks, M J Dunn, M A Forbes, et al.
British Journal of Cancer|March 1, 1989
The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantationP J Selby, R L Powles, D Easton, et al.
Cancer Gene Therapy|August 13, 2011
Adenovirus-mediated hypoxia-targeted gene therapy using HSV thymidine kinase and bacterial nitroreductase prodrug-activating genes in vitro and in vivoT J Harvey, I M Hennig, S D Shnyder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
High-dose melphalan for multiple myeloma: long-term follow-up dataD Cunningham, L Paz-Ares, M E Gore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Automated collection of quality-of-life data: a comparison of paper and computer touch-screen questionnairesG Velikova, E P Wright, A B Smith, et al.
British Journal of Cancer|November 11, 2010
Improving the accuracy of pre-operative survival prediction in renal cell carcinoma with C-reactive proteinS P K Jagdev, W Gregory, N S Vasudev, et al.
Hybridoma|August 1, 1997
Production and characterization of monoclonal antibodies to human interleukin-12R W Carter, P M Patel, A J Stanley, et al.
British Journal of Cancer|March 2, 2013
miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosisR I McCormick, C Blick, J Ragoussis, et al.
British Journal of Cancer|December 1, 1988
High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytomaE K Mbidde, P J Selby, T J Perren, et al.
British Journal of Haematology|December 21, 2000
Persistence of clonal T-cell expansions following high-dose chemotherapy and autologous peripheral blood progenitor cell rescueA S Protheroe, C Pickard, P W Johnson, et al.
Pageof 11